Cargando…
Hospitalized COVID-19 patients treated with convalescent plasma in a mid-size city in the Midwest
BACKGROUND: SARS-CoV-2 and its associated disease, COVID-19, has infected over seven million people world-wide, including two million people in the United States. While many people recover from the virus uneventfully, a subset of patients will require hospital admission, some with intensive care nee...
Autores principales: | Hartman, William R., Hess, Aaron S., Connor, Joseph P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549340/ https://www.ncbi.nlm.nih.gov/pubmed/33072871 http://dx.doi.org/10.1186/s41231-020-00068-9 |
Ejemplares similares
-
Hospitalized COVID-19 Patients treated with Convalescent Plasma in a Mid-size City in the Midwest
por: Hartman, William R, et al.
Publicado: (2020) -
Hospitalized COVID-19 Patients treated with Convalescent Plasma in a Mid-size City in the Midwest
por: Hartman, William R, et al.
Publicado: (2020) -
Unusual Cardiac Presentation of COVID-19 and Use of Convalescent Plasma
por: Hartman, William R., et al.
Publicado: (2020) -
Convalescent plasma to treat COVID-19
por: Bloch, Evan M.
Publicado: (2020) -
The Challenge of Recruiting Convalescent Plasma Donors during the COVID-19 Pandemic: Preliminary Results from a Single Center in Midwest Brazil
por: Roberti, Maria do Rosario Ferraz, et al.
Publicado: (2020)